Study of AZD9833 Alone or in Combination in Women with Advanced Breast Cancer.

Trial Identifier: D8530C00001
Sponsor: AstraZeneca
NCTID:: NCT03616587
Start Date: October 2018
Primary Completion Date: July 2024
Study Completion Date: September 2024
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
ES Barcelona, ES, 8036
ES Barcelona, ES, 08035
ES Madrid, ES, 28041
ES Madrid, ES, 28050
ES Sevilla, ES, 41013
ES Valencia, ES, 46010
GB Cambridge, GB, CB2 0QQ
GB Leeds, GB, LS9 7TF
GB London, GB, SW2 6JJ
GB Manchester, GB, M20 4GJ
GB Sutton, GB, SM2 5PT
GB Sutton, GB, SM1 2DL
US, CO Aurora, CO, US, 80045
US, FL Sarasota, FL, US, 34232
US, PA Philadelphia, PA, US, 19111
US, TN Nashville, TN, US, 37203
US, UT Salt Lake City, UT, US, 84112